Welcome to the American Foundation for Pharmaceutical Education website. For over 75 years, AFPE has been committed to supporting pharmaceutical education for the greater good. As a non-profit organization, AFPE relies on donations in order to fund scholarships and grants that are awarded to aspiring and current researchers and academics in the pharmaceutical sciences arena so that they may have the resources necessary to conduct novel research projects that will impact the future of healthcare and patient outcomes.
Thank you for visiting and learning more about the American Foundation for Pharmaceutical Education and its rich history.
AFPE announces the Pre-Doctoral Award in Health Outcome Disparities
AFPE is excited to announce a new designated fellowship for a pre-doctoral student whose research focuses on either a disease area which disproportionately impacts underserved populations, or whose research focuses on reducing healthcare disparities and improving health outcomes for underserved populations in the United States. Examples of this research could include: sickle-cell anemia, asthma, HIV/AIDS, maternal and infant mortality, access to medication, etc.
Applicants to this award who are not selected will automatically be considered for a Pre-Doctoral Award in Pharmaceutical Sciences. The same eligibility requirements and deadlines apply for both awards.
Congratulations to Daniel Hussar, a former AFPE fellow, for receiving the prestigious Remington Award. The Remington is the highest honor in the Pharmaceutical Science Profession. Click here to read more about Dr. Hussar!
AFPE celebrates Dr. William Heller’s many years of service on the Board of Directors, and announces the William M. Heller Mentor of the Year Award in his honor. We are so grateful for his lifelong contributions to the Pharmaceutical Sciences profession and to AFPE.
AFPE is addressing the Opioid Crisis by funding projects like:
- “Probing a New Target HINT1 for the Management of Chronic Pain through Analgesia and the Reversal of Opioid Tolerance” (Dr. Carston Wagner and Ph.D Candidate Alexander Strom, University of Minnesota)
- “Community Pharmacists’ Attitudes, Beliefs, and Behaviors in Dispensing Naloxone Under a Standing Order”(Dr. Norman Carroll and Pharm.D Candidate Elena V. Fernandez, Virginia Commonwealth University)
- “Impact of Opioid Dosing Strategies on Pain Scores and Adverse or Unintended Clinical Outcomes” (Drs. Brad Martin and Teresa Hudson, and Ph.D Candidate Corey Hayes, University of Arkansas for Medical Sciences)
2017 AFPE Fellow, Ashley Cole, MPH, is researching the “Comparative Effectiveness and Safety of First-Line Chemotherapeutic Regimens for Unresectable Pancreatic Cancer.” Read more here!
2017 Pre-Doctoral Fellows
2017 Gateway to Research Scholars
Our 2017 Brochure is Now Available! Click here for more information about all of our Pre-Doc, Gateway, and First-Year awardees!
AFPE Celebrates Gordon Amidon, Our 2017 Mentor of the Year!
Dr. Amidon is the Charles R. Walgreen Jr. Professor of Pharmacy at the University of Michigan. Click here to read more about Dr. Amidon’s mentorship and the impact he has had on his students.
Brandon Lucke-Wolde not only works to improve our health, he is also working to make life better for lab animals. What is SwifTag? Lucke-Wolde, a current AFPE Fellow, alongside two of his peers, are working to develop “SwifTag,” which is “an ear tag that uses state-of-the-art radio frequency identification and a smart phone reader to collect data for animal inventory” and will reduce unnecessary animal handling and chances for human error. Lucke-Wolde and his partners have already received pilot funding for their prototype, and are in the process of filing for a provisional patent and their LLC. Lucke-Wold and his partners have been selected to participate in the semi-finals of Pitch Austin, hosted by the McCombs School of Business during the March 15th South by Southwest Conference. For more information on SwifTag and Pitch Austin, please click here.
For more information on Lucke-Wolde’s other accomplishments, please click here.